Found 3 results
Filters: Author is E.M.M. Cerqueira  [Clear All Filters]
L. Pereira, Carvalho, M. R. S., Fonseca, C. G., Lima, S. S. S., Cerqueira, E. M. M., Jorge, W., and Castro, M. C. L., Influence of Arg72Pro polymorphisms of TP53 on the response of buccal cells to radiotherapy, vol. 10. pp. 3552-3558, 2011.
Bindu L, Balaram P, Mathew A, Remani P, et al. (2003). Radiation-induced changes in oral carcinoma cells - a multiparametric evaluation. Cytopathology 14: 287-293. PMid:14510894   Bloching M, Hofmann A, Lautenschlager C, Berghaus A, et al. (2000). Exfoliative cytology of normal buccal mucosa to predict the relative risk of cancer in the upper aerodigestive tract using the MN-assay. Oral Oncol. 36: 550-555.   Bonassi S, Znaor A, Ceppi M, Lando C, et al. (2007). An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28: 625-631. PMid:16973674   Bonassi S, El-Zein R, Bolognesi C and Fenech M (2011). Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies. Mutagenesis 26: 93-100. PMid:21164188   Burgaz S, Coskun E, Demircigil GC, Kocabas NA, et al. (2011). Micronucleus frequencies in lymphocytes and buccal epithelial cells from patients having head and neck cancer and their first-degree relatives. Mutagenesis 26: 351-356. PMid:21248276   Cerqueira EMM, Gomes-Filho IS, Trindade S, Lopes MA, et al. (2004). Genetic damage in exfoliated cells from oral mucosa of individuals exposed to X-rays during panoramic dental radiographies. Mutat. Res. 562: 111-117. PMid:15279834   Dumont P, Leu JI, Pietra ACD, George DL, et al. (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 33: 357-365. PMid:12567188   Ezzikouri S, El Feydi AE, Chafik A, Benazzouz M, et al. (2007). The Pro variant of the p53 codon 72 polymorphism is associated with hepatocellular carcinoma in Moroccan population. Hepatol. Res. 37: 748-754. PMid:17573955   Fenech M and Bonassi S (2011). The effect of age, gender, diet and lifestyle on DNA damage measured using micronucleus frequency in human peripheral blood lymphocytes. Mutagenesis 26: 43-49. PMid:21164181   Feulgen R and Rossenbeck H (1924). Mikorskopisch-chemischer nachweis einer nucleinsaure von typus der thymonucleisaure und die darauf beruhende elektive farbung vom zellkernen in mikroskopischen praparaten. Z. Phys. Chem. 135: 203-248.   Green DR and Kroemer G (2009). Cytoplasmic functions of the tumour suppressor p53. Nature 458: 1127-1130. PMid:19407794 PMCid:2814168   Jianlin L, Jiliang H, Lifen J, Wei Z, et al. (2004). Measuring the genetic damage in cancer patients during radiotherapy with three genetic end-points. Mutagenesis 19: 457-464. PMid:15548757   Miller SA, Dykes DD and Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215. PMid:3344216 PMCid:334765   Norppa H and Falck GC (2003). What do human micronuclei contain? Mutagenesis 18: 221-233. PMid:12714687   Ramirez A and Saldanha PH (2002). Micronucleus investigation of alcoholic patients with oral carcinomas. Genet. Mol. Res. 1: 246-260. PMid:14963832   Raymond M and Rousset F (1995). GENEPOP (version 1.2) population genetic software for exact tests and ecumenicism. J. Heredity 86: 248-249.   Shidnia H, Crabtree W, Hornback N, Young P, et al. (1990). Micronuclei assay - a predictive variable for tumor response to treatment. Adv. Exp. Med. Biol. 267: 51-55. PMid:1965096   Sokal RR and Rohlf FJ (1995). The Normal Probability Distribution. In: Biometry. 3rd edn. W.H. Freeman and Company, New York, 116-123.   Tolbert PE, Shy CM and Allen JW (1992). Micronuclei and other nuclear anomalies in buccal smears: methods development. Mutat. Res. 271: 69-77.   Whibley C, Pharoah PD and Hollstein M (2009). p53 polymorphisms: cancer implications. Nat. Rev. Cancer 9: 95-107. PMid:19165225
G. M. A. Aires, Meireles, J. R. C., Oliveira, P. C., Oliveira, J. L., Araújo, E. L., Pires, B. C., Cruz, E. S. A., Jesus, N. F., Pereira, C. A. B., and Cerqueira, E. M. M., Micronuclei as biomarkers for evaluating the risk of malignant transformation in the uterine cervix, vol. 10, pp. 1558-1564, 2011.
Arrossi S, Sankaranarayanan R and Parkin DM (2003). Incidence and mortality of cervical cancer in Latin America. Salud Publica Mex. 45 (Suppl 3): S306-S314. Bragança-Pereira CA (1991). Teste Estatístico para Comparar Proporções em Problemas de Citogenética. In: Mutagênese, Carcinogênese e Teratogênese: Métodos e Critérios de Avaliação (Rabello-Gay MN, Rodrigues M and Monteleone- Neto R, eds.). Sociedade Brasileira de Genética, Ribeirão Preto, 113-121. Campos LMFR, Dias FL, Antunes LMG and Murta EFC (2008). Prevalence of micronuclei in exfoliated uterine cervical cells from patients with risk factors for cervical cancer. São Paulo Med. J. 126: 323-328. Cerqueira EM, Santoro CL, Donozo NF, Freitas BA, et al. (1998). Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation? Acta Cytol. 42: 639-649. PMid:9622681 Chakrabarti RN and Dutta K (1988). Micronuclei test in routine smears from uterine cervix. Eur. J. Gynaecol. Oncol. 9: 370-372. PMid:3224608 Follen M, Crain S, Macaulay C, Basen-Engquist K, et al. (2005). Optical technologies for cervical neoplasia: update of an NCI program project grant. Clin. Adv. Hematol. Oncol. 3: 41-53. PMid:16166967 Gandhi G and Kaur B (2003). Elevated frequency of micronuclei in uterine smears of cervix cancer patients. Caryologia 56: 217-222. Guzman P, Sotelo-Regil RC, Mohar A and Gonsebatt ME (2003). Positive correlation between the frequency of micronucleated cells and dysplasia in Papanicolaou smears. Environ. Mol. Mutagen. 41: 339-343. PMid:12802804 Holland N, Bolognesi C, Kirsch-Volders M, Bonassi S, et al. (2008). The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: the HUMN project perspective on current status and knowledge gaps. Mutat. Res. 659: 93-108. PMid:18514568 Holowaty P, Miller AB, Rohan T and To T (1999). Natural history of dysplasia of the uterine cervix. J. Natl. Cancer Inst. 91: 252-258. INCA (2009). Ministério da Saúde. Instituto Nacional de Câncer. Estimativa 2010: Incidência de Câncer no Brasil. Available at []. Accessed November 15, 2010. Leal-Garza CH, Cerda-Flores RM, Leal-Elizondo E and Cortes-Gutierrez EI (2002). Micronuclei in cervical smears and peripheral blood lymphocytes from women with and without cervical uterine cancer. Mutat. Res. 515: 57-62. PMid:11909754 Leyden WA, Manos MM, Geiger AM, Weinmann S, et al. (2005). Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J. Natl. Cancer Inst. 97: 675-683. PMid:15870438 Nersesyan AK (2007). Possible role of the micronucleus assay in diagnostics and secondary prevention of cervix cancer: a minireview. Cytol. Genet. 41: 317-318. Rogovskaya SI, Sukhikh GT, Zhdanov AV, Kolobova EA, et al. (2001). Apoptosis in woman uterine cervix in pathologies associated with human papillomavirus. Bull. Exp. Biol. Med. 131: 576-582. PMid:11586412 Sarto F, Finotto S, Giacomelli L, Mazzotti D, et al. (1987). The micronucleus assay in exfoliated cells of the human buccal mucosa. Mutagenesis 2: 11-17. PMid:3331688 Sheets EE, Crum CP and Yeh J (1996). Association between cervical neoplasia and apoptosis as detected by in situ nuclear labeling. Gynecol. Oncol. 63: 94-100. PMid:8898176 Tirado-Gómez LL, Mohar-Betancourt A, López-Cervantes M, García-Carrancá A, et al. (2005). Factores de riesgo de cáncer cervicouterino invasor en mujeres mexicanas. Salud Publica Mex. 47: 342-350. PMid:16323527 Tolbert PE, Shy CM and Allen JW (1992). Micronuclei and other nuclear anomalies in buccal smears: methods development. Mutat. Res. 271: 69-77. PMid:1371831 Zhdanov AV, Kurbanova DF, Davydova MP, Sosulina LY, et al. (2003). Apoptosis in fimbriae of fallopian tubes and endometrium in pyoinflammatory adnexal diseases. Bull. Exp. Biol. Med. 135: 150-153. PMid:12802421